Insulin aspart, recombinant Subcutaneous and UTA Capsules
Determining the interaction of Insulin aspart, recombinant Subcutaneous and UTA Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-UTAC tablets
- Insulin aspart, recombinant Subcutaneous-UTI Relief
- Insulin aspart, recombinant Subcutaneous-Utibron Neohaler
- Insulin aspart, recombinant Subcutaneous-Uticap
- Insulin aspart, recombinant Subcutaneous-Utira-C
- Insulin aspart, recombinant Subcutaneous-Utira-C Tablets
- UTA Capsules-Insulin degludec
- UTA Capsules-Insulin Degludec (U-100) Prefilled Pens
- UTA Capsules-Insulin Degludec (U-100) Vials
- UTA Capsules-Insulin Degludec (U-200) Prefilled Pens
- UTA Capsules-Insulin degludec and liraglutide
- UTA Capsules-Insulin degludec and liraglutide Subcutaneous